WELLS FARGO & COMPANY/MN - OMEGA THERAPEUTICS INC ownership

OMEGA THERAPEUTICS INC's ticker is and the CUSIP is 68217N105. A total of 59 filers reported holding OMEGA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of OMEGA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$39,328
-30.8%
18,292
+80.4%
0.00%
Q2 2023$56,795
+7554.3%
10,142
+8145.5%
0.00%
Q1 2023$742
+7.4%
123
+1.7%
0.00%
Q4 2022$691
-30.9%
121
+2.5%
0.00%
Q3 2022$1,000118
+131.4%
0.00%
Q2 2022$0
-100.0%
51
-99.6%
0.00%
Q1 2022$89,000
-40.7%
14,327
+8.4%
0.00%
Q4 2021$150,000
+14900.0%
13,216
+32134.1%
0.00%
Q3 2021$1,000410.00%
Other shareholders
OMEGA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 352,941$758,8235.08%
Flagship Pioneering Inc. 29,225,579$62,834,9964.56%
HARBOURVEST PARTNERS LLC 3,512,110$7,551,0372.56%
CHI Advisors LLC 1,055,882$2,270,1460.90%
Knoll Capital Management, LLC 173,010$371,9710.39%
Artal Group S.A. 2,533,045$5,4460.23%
683 Capital Management, LLC 508,242$1,092,7200.08%
PLATINUM INVESTMENT MANAGEMENT LTD 887,017$1,907,0870.07%
ORACLE INVESTMENT MANAGEMENT INC 50,000$107,5000.03%
STATE OF WISCONSIN INVESTMENT BOARD 1,857,265$3,993,1200.01%
View complete list of OMEGA THERAPEUTICS INC shareholders